{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T03:41:24Z","timestamp":1790134884233,"version":"4.0.1"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100018531","name":"Major Science and Technology Projects in Yunnan Province","doi-asserted-by":"publisher","award":["202302AA310046-04"],"award-info":[{"award-number":["202302AA310046-04"]}],"id":[{"id":"10.13039\/501100018531","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013114","name":"Yunnan Key Research and Development Program","doi-asserted-by":"publisher","award":["202403AC3100014-2"],"award-info":[{"award-number":["202403AC3100014-2"]}],"id":[{"id":"10.13039\/501100013114","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81960479"],"award-info":[{"award-number":["81960479"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82360555"],"award-info":[{"award-number":["82360555"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.prp.2026.156652","type":"journal-article","created":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T15:33:47Z","timestamp":1786548827000},"page":"156652","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["ACOD1 enhances the ferroptosis resistance of tumor-associated macrophages through the KEAP1\/NRF2 axis and promotes triple-negative breast cancer progression"],"prefix":"10.1016","volume":"287","author":[{"given":"Jie","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiyin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaxi","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-5652-7454","authenticated-orcid":false,"given":"Qi","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuoyou","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruoxi","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianyun","family":"Nie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.prp.2026.156652_bib1","first-page":"297","article-title":"Five-year conditional relative survival up to 10 years post-diagnosis among adolescent and young adult breast cancer patients by age, stage, and receptor subtype","volume":"5","author":"Vrancken Peeters","year":"2025","journal-title":"J. Natl. Cancer Cent."},{"key":"10.1016\/j.prp.2026.156652_bib2","article-title":"Deregulated MicroRNAs involved in P53 signaling pathway in breast cancer with focus on triple-negative breast cancer","volume":"17","author":"Naeimzadeh","year":"2024","journal-title":"Curr. Mol. Pharmacol."},{"issue":"5","key":"10.1016\/j.prp.2026.156652_bib3","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.3390\/cancers14051253","article-title":"Triple negative breast cancer: updates on classification and treatment in 2021","volume":"14","author":"Bou Zerdan","year":"2022","journal-title":"Cancers"},{"issue":"9","key":"10.1016\/j.prp.2026.156652_bib4","doi-asserted-by":"crossref","DOI":"10.1002\/cam4.70803","article-title":"Targeting triple-negative breast cancer: resistance mechanisms and therapeutic advancements","volume":"14","author":"Raman","year":"2025","journal-title":"Cancer Med."},{"issue":"1","key":"10.1016\/j.prp.2026.156652_bib5","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/s13045-022-01341-0","article-title":"Recent advances in therapeutic strategies for triple-negative breast cancer","volume":"15","author":"Li","year":"2022","journal-title":"J. Hematol. & Oncol."},{"key":"10.1016\/j.prp.2026.156652_bib6","article-title":"Tumor-Associated Macrophages: Key Players in Triple-Negative Breast Cancer","volume":"12","author":"Qiu","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.prp.2026.156652_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2026.218278","article-title":"FIG4 downregulation-arrested autophagy-lysosomal degradation of IL-18 drives lipid-associated macrophage polarization and immunotherapy resistance in triple-negative breast cancer","volume":"641","author":"Xia","year":"2026","journal-title":"Cancer Lett."},{"key":"10.1016\/j.prp.2026.156652_bib8","article-title":"Harnessing plant-derived natural compounds to target ferroptosis, pyroptosis, immune modulation and renin-angiotensin system in renal cell carcinoma","volume":"26","author":"Wang","year":"2025","journal-title":"J. ReninAngiotensinAldosterone Syst."},{"issue":"2","key":"10.1016\/j.prp.2026.156652_bib9","first-page":"239","article-title":"Ferroptosis in Pneumoconiosis: From Molecular and Cellular Mechanisms to Therapeutic Strategies","volume":"1","author":"Yan","year":"2025","journal-title":"Med Res."},{"issue":"1","key":"10.1016\/j.prp.2026.156652_bib10","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.cmp.2026.03.001","article-title":"Gramine suppresses triple-negative breast cancer by inducing ferroptosis via CUL3-mediated ubiquitination of MTDH","volume":"19","author":"Zhou","year":"2026","journal-title":"Curr. Mol. Pharmacol."},{"issue":"10","key":"10.1016\/j.prp.2026.156652_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.lddd.2025.100169","article-title":"Research on the mechanism by which quercetin affects ferroptosis in breast cancer cells through regulating USP9X\/PIAS4","volume":"22","author":"Fu","year":"2025","journal-title":"Lett. Drug Des. & Discov."},{"key":"10.1016\/j.prp.2026.156652_bib12","doi-asserted-by":"crossref","first-page":"6189","DOI":"10.2147\/IJGM.S329031","article-title":"Evaluation of Ferroptosis-related Gene AKR1C1 as a Novel Biomarker Associated with the Immune Microenvironment and Prognosis in Breast Cancer","volume":"14","author":"Zhang","year":"2021","journal-title":"Int. J. Gen. Med."},{"issue":"7","key":"10.1016\/j.prp.2026.156652_bib13","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adk1835","article-title":"Mutant p53 protects triple-negative breast adenocarcinomas from ferroptosis in vivo","volume":"10","author":"Dibra","year":"2024","journal-title":"Sci. Adv."},{"key":"10.1016\/j.prp.2026.156652_bib14","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.jare.2024.09.027","article-title":"Salidroside sensitizes Triple-negative breast cancer to ferroptosis by SCD1-mediated lipogenesis and NCOA4-mediated ferritinophagy","volume":"74","author":"Huang","year":"2025","journal-title":"J. Adv. Res."},{"issue":"1","key":"10.1016\/j.prp.2026.156652_bib15","first-page":"315","article-title":"Ferroptosis and the tumor microenvironment","volume":"43","author":"Cui","year":"2024","journal-title":"Journal experimental & clinical cancer research CR"},{"issue":"23","key":"10.1016\/j.prp.2026.156652_bib16","doi-asserted-by":"crossref","first-page":"4734","DOI":"10.1158\/0008-5472.CAN-24-4949","article-title":"CLK2 Regulates the KEAP1\/NRF2 and p53 Pathways to Suppress Ferroptosis in Colorectal Cancer","volume":"85","author":"Zhou","year":"2025","journal-title":"Cancer Res."},{"issue":"17","key":"10.1016\/j.prp.2026.156652_bib17","doi-asserted-by":"crossref","first-page":"5622","DOI":"10.7150\/jca.96608","article-title":"miR-141-3p promotes paclitaxel resistance by attenuating ferroptosis via the Keap1-Nrf2 signaling pathway in breast cancer","volume":"15","author":"Duan","year":"2024","journal-title":"J. Cancer"},{"issue":"2","key":"10.1016\/j.prp.2026.156652_bib18","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jointm.2022.01.001","article-title":"Mitochondrial ACOD1\/IRG1 in infection and sterile inflammation","volume":"2","author":"Wu","year":"2022","journal-title":"J. Intensive Med."},{"issue":"8","key":"10.1016\/j.prp.2026.156652_bib19","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1038\/s41423-020-0489-5","article-title":"ACOD1 in immunometabolism and disease","volume":"17","author":"Wu","year":"2020","journal-title":"Cell. & Mol. Immunol."},{"issue":"3","key":"10.1016\/j.prp.2026.156652_bib20","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.62347\/LHYO6433","article-title":"Itaconate targets the ERK2 signal to suppress estrogen receptor-positive breast cancer cell growth","volume":"15","author":"Wang","year":"2025","journal-title":"Am. J. Cancer Res."},{"issue":"10","key":"10.1016\/j.prp.2026.156652_bib21","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1016\/j.cmet.2023.09.004","article-title":"Neutrophils resist ferroptosis and promote breast cancer metastasis through aconitate decarboxylase 1","volume":"35","author":"Zhao","year":"2023","journal-title":"Cell Metab."},{"issue":"12","key":"10.1016\/j.prp.2026.156652_bib22","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1016\/j.ccell.2024.10.010","article-title":"Itaconate transporter SLC13A3 impairs tumor immunity via endowing ferroptosis resistance","volume":"42","author":"Lin","year":"2024","journal-title":"Cancer Cell"},{"issue":"7699","key":"10.1016\/j.prp.2026.156652_bib23","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/nature25986","article-title":"Itaconate is an anti-inflammatory metabolite that activates Nrf2 via alkylation of KEAP1","volume":"556","author":"Mills","year":"2018","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.prp.2026.156652_bib24","doi-asserted-by":"crossref","first-page":"4587","DOI":"10.1002\/ptr.7578","article-title":"Andrographolide suppresses breast cancer progression by modulating tumor-associated macrophage polarization through the Wnt\/\u03b2-catenin pathway","volume":"36","author":"Li","year":"2022","journal-title":"Phytother. Res. PTR"},{"issue":"17","key":"10.1016\/j.prp.2026.156652_bib25","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adg0654","article-title":"Targeting IRG1 reverses the immunosuppressive function of tumor-associated macrophages and enhances cancer immunotherapy","volume":"9","author":"Chen","year":"2023","journal-title":"Sci. Adv."},{"issue":"9","key":"10.1016\/j.prp.2026.156652_bib26","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1002\/1878-0261.12319","article-title":"Basal-like breast cancer engages tumor-supportive macrophages via secreted factors induced by extracellular S100A4","volume":"12","author":"Prasmickaite","year":"2018","journal-title":"Mol. Oncol."},{"issue":"1","key":"10.1016\/j.prp.2026.156652_bib27","doi-asserted-by":"crossref","first-page":"174","DOI":"10.3390\/cells9010174","article-title":"Modulating tumor-associated macrophage polarization by synthetic and natural PPAR\u03b3 ligands as a potential target in breast cancer","volume":"9","author":"Gionfriddo","year":"2020","journal-title":"Cells"},{"issue":"4","key":"10.1016\/j.prp.2026.156652_bib28","first-page":"861","article-title":"[Effect of DOT1L gene silence on proliferation of acute monocytic leukemia cell line THP-1]","volume":"21","author":"Zhang","year":"2013","journal-title":"Zhongguo shi yan xue ye xue za zhi"},{"issue":"3","key":"10.1016\/j.prp.2026.156652_bib29","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1038\/s41589-019-0462-8","article-title":"Redox lipid reprogramming commands susceptibility of macrophages and microglia to ferroptotic death","volume":"16","author":"Kapralov","year":"2020","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.prp.2026.156652_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2022.102591","article-title":"Itaconate promotes a wound resolving phenotype in pro-inflammatory macrophages","volume":"59","author":"Maassen","year":"2023","journal-title":"Redox Biol."},{"issue":"10","key":"10.1016\/j.prp.2026.156652_bib31","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1038\/s41419-024-07123-5","article-title":"Tumor-associated macrophages\/C-X-C motif chemokine ligand 1 promotes breast cancer autophagy-mediated chemoresistance via IGF1R\/STAT3\/HMGB1 signaling","volume":"15","author":"Yang","year":"2024","journal-title":"Cell death & Dis."},{"issue":"8","key":"10.1016\/j.prp.2026.156652_bib32","first-page":"1528","article-title":"Baicalein suppress EMT of breast cancer by mediating tumor-associated macrophages polarization","volume":"8","author":"Zhao","year":"2018","journal-title":"Am. J. Cancer Res."},{"issue":"1","key":"10.1016\/j.prp.2026.156652_bib33","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1186\/s12951-024-02694-z","article-title":"Determining M2 macrophages content for the anti-tumor effects of metal-organic framework-encapsulated pazopanib nanoparticles in breast cancer","volume":"22","author":"Xu","year":"2024","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.prp.2026.156652_bib34","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/9720912","article-title":"New Mechanisms of Tumor-Associated Macrophages on Promoting Tumor Progression: Recent Research Advances and Potential Targets for Tumor Immunotherapy","volume":"2016","author":"Guo","year":"2016","journal-title":"J. Immunol. Res."},{"key":"10.1016\/j.prp.2026.156652_bib35","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1441820","article-title":"Tumor associated macrophages in breast cancer progression: implications and clinical relevance","volume":"15","author":"Stavrou","year":"2024","journal-title":"Front. Immunol."},{"issue":"19","key":"10.1016\/j.prp.2026.156652_bib36","doi-asserted-by":"crossref","first-page":"10781","DOI":"10.3390\/ijms251910781","article-title":"Macrophages: Key Players in the Battle against Triple-Negative Breast Cancer","volume":"25","author":"Padzi\u0144ska-Pruszy\u0144ska","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.prp.2026.156652_bib37","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.cmet.2022.02.002","article-title":"Itaconate and itaconate derivatives target JAK1 to suppress alternative activation of macrophages","volume":"34","author":"Runtsch","year":"2022","journal-title":"Cell Metab."},{"key":"10.1016\/j.prp.2026.156652_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2023.122386","article-title":"Biomimetic inducer enabled dual ferroptosis of tumor and M2-type macrophages for enhanced tumor immunotherapy","volume":"303","author":"Chen","year":"2023","journal-title":"Biomaterials"},{"issue":"10","key":"10.1016\/j.prp.2026.156652_bib39","doi-asserted-by":"crossref","first-page":"759","DOI":"10.2174\/0109298665333926240927074528","article-title":"Ferroptosis as a Therapeutic Target in Neurodegenerative Diseases: Exploring the Mechanisms and Potential of Treating Alzheimer's Disease and Parkinson's Disease","volume":"31","author":"Zhong","year":"2024","journal-title":"Protein Pept. Lett."},{"issue":"1","key":"10.1016\/j.prp.2026.156652_bib40","doi-asserted-by":"crossref","first-page":"14","DOI":"10.2174\/0118744710262369231110065230","article-title":"Ferroptosis Inducers as Promising Radiosensitizer Agents in Cancer Radiotherapy","volume":"17","author":"Zefrei","year":"2024","journal-title":"Curr. Radiopharm."},{"key":"10.1016\/j.prp.2026.156652_bib41","first-page":"26","article-title":"Ferroptosis-related gene DUSP1 improves renal fibrosis in immunoglobulin A nephropathy through regulating p38 MAPK\/Nrf2-induced ferroptosis","author":"Gu","year":"2025","journal-title":"J. ReninAngiotensinAldosterone Syst. 2025"},{"issue":"9","key":"10.1016\/j.prp.2026.156652_bib42","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1038\/s41418-024-01351-0","article-title":"Phospholipid peroxidation in macrophage confers tumor resistance by suppressing phagocytic capability towards ferroptotic cells","volume":"31","author":"Luo","year":"2024","journal-title":"Cell death Differ."},{"issue":"2","key":"10.1016\/j.prp.2026.156652_bib43","article-title":"Targeted xCT-mediated Ferroptosis and Protumoral Polarization of Macrophages Is Effective against HCC and Enhances the Efficacy of the Anti-PD-1\/L1 Response","volume":"10","author":"Tang","year":"2023","journal-title":"Advanced science (Weinheim BadenWurttemberg Germany)"},{"issue":"3","key":"10.1016\/j.prp.2026.156652_bib44","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s00277-020-03916-8","article-title":"M2-like polarization of THP-1 monocyte-derived macrophages under chronic iron overload","volume":"99","author":"Kao","year":"2020","journal-title":"Ann. Hematol."},{"issue":"8","key":"10.1016\/j.prp.2026.156652_bib45","first-page":"743","article-title":"Progress on iron metabolism and ferroptosis in macrophages]. Xi bao yu fen zi mian yi xue za","volume":"40","author":"Ba","year":"2024","journal-title":"zhi = Chin. J. Cell. Mol. Immunol."},{"key":"10.1016\/j.prp.2026.156652_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2025.120768","article-title":"Cistanche attenuates acute kidney injury by inhibiting ferroptosis through the disruption of Keap1-Nrf2 interaction","volume":"356","author":"Xian","year":"2026","journal-title":"J. Ethnopharmacol."},{"issue":"6","key":"10.1016\/j.prp.2026.156652_bib47","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2023-006890","article-title":"PRMT5 reduces immunotherapy efficacy in triple-negative breast cancer by methylating KEAP1 and inhibiting ferroptosis","volume":"11","author":"Wang","year":"2023","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.prp.2026.156652_bib48","article-title":"EDEM1 Inhibits Endoplasmic Reticulum Stress to Induce Doxorubicin Resistance through Accelerating ERAD and Activating Keap1\/Nrf2 Antioxidant Pathway in Triple-Negative Breast Cancer","volume":"8","author":"Wang","year":"2025","journal-title":"Res. (Wash. DC)"},{"issue":"7","key":"10.1016\/j.prp.2026.156652_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2022.104561","article-title":"The STING1-MYD88 complex drives ACOD1\/IRG1 expression and function in lethal innate immunity","volume":"25","author":"Chen","year":"2022","journal-title":"iScience"},{"issue":"41","key":"10.1016\/j.prp.2026.156652_bib50","doi-asserted-by":"crossref","first-page":"16386","DOI":"10.1021\/ja2070889","article-title":"Itaconic acid is a mammalian metabolite induced during macrophage activation","volume":"133","author":"Strelko","year":"2011","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.prp.2026.156652_bib51","first-page":"979","article-title":"4-Octyl Itaconate Activates Nrf2 Signaling to Inhibit Pro-Inflammatory Cytokine Production in Peripheral Blood Mononuclear Cells of Systemic Lupus Erythematosus Patients","volume":"51","author":"Tang","year":"2018"},{"issue":"4","key":"10.1016\/j.prp.2026.156652_bib52","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.1661","article-title":"ACOD1, rather than itaconate, facilitates p62-mediated activation of Nrf2 in microglia post spinal cord contusion","volume":"14","author":"Qian","year":"2024","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.prp.2026.156652_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2020.102832","article-title":"Itaconate prevents abdominal aortic aneurysm formation through inhibiting inflammation via activation of Nrf2","volume":"57","author":"Song","year":"2020","journal-title":"EBioMedicine"},{"issue":"4","key":"10.1016\/j.prp.2026.156652_bib54","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1002\/hep.31147","article-title":"Immune-Responsive Gene 1\/Itaconate activates nuclear factor erythroid 2-related factor 2 in hepatocytes to protect against liver ischemia-reperfusion injury","volume":"72","author":"Yi","year":"2020","journal-title":"Hepatol. (Baltim. Md)"}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033826003055?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033826003055?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T06:38:03Z","timestamp":1788763083000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0344033826003055"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":54,"alternative-id":["S0344033826003055"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2026.156652","relation":{},"ISSN":["0344-0338"],"issn-type":[{"value":"0344-0338","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"ACOD1 enhances the ferroptosis resistance of tumor-associated macrophages through the KEAP1\/NRF2 axis and promotes triple-negative breast cancer progression","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2026.156652","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier GmbH. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"156652"}}